LL37 is commonly discussed in immune and barrier-support conversations, especially by people interested in the body’s first-line defense systems. It has a different feel from recovery or metabolic peptides because the discussion usually centers on resilience, microbial balance, and tissue defense. It fits customers who want a more specialized peptide in the immune-support category.






